Influence of the immunostimulating compound azimexone(2-[2-Cyanaziridin,yl-(1)]-2-[2-carbamoylaziridin,yl-(1)]-propane) on the number of metastases in the Lewis lung carcinoma in mice
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Experimental pathology
- Vol. 19 (1) , 15-18
- https://doi.org/10.1016/s0232-1513(81)80049-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Immunomodulation by the new synthetic compound BM 12.531,2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone)Experimental pathology, 1981
- The Immunomodulatory Effect of Bm 12.531 (Azimexon) on Normal or Tumored Mice: In Vitro and in Vivo StudiesJournal of Immunopharmacology, 1980
- Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(l)]-propane BM 12 531Experimentelle Pathologie, 1978
- Hydrocortisone Affects Tumor Growth by Eliminating Precursors of Suppressor CellsThe Journal of Immunology, 1977
- Lewis Lung Tumor System as a Model for Studying the Immune Function in Syngeneic ↔ Allogeneic ChimerasOncology, 1976
- SYNGENEIC METASTATIC TUMOR MODEL IN MICE - NATURAL IMMUNE-RESPONSE OF HOST AND ITS MANIPULATION1976
- Accurate Identification of Experimental Pulmonary Metastases2JNCI Journal of the National Cancer Institute, 1966